MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer

Published:2016-08-12 Issue:8 Volume:11 Page:e0158961
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yu Beiqin,Lv Xin,Su Liping,Li Jianfang,Yu Yingyan,Gu Qinlong,Yan Min,Zhu Zhenggang,Liu Bingya

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Key Projects in the National Science & Technology Pillar Program of China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Comparisons of Gastric Cancer Treatments: East vs. West;K Bickenbach;Journal of gastric cancer,2012

2. MicroRNAs: target recognition and regulatory functions;DP Bartel;Cell,2009

3. Overview of microRNA biology;AM Mohr;Seminars in liver disease,2015

4. Genetic mutation of p53 and suppression of the miR-17 approximately 92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling;R Borkowski;Cancer research,2015

5. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy;Q Zheng;The Prostate,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer;Health Science Reports;2024-07

2. Analyzing omics data based on sample network;Journal of Bioinformatics and Computational Biology;2024-02

3. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications;Biomolecules;2023-10-28

4. Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1;Oncotarget;2023-06-12

5. Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response;Medicinal Research Reviews;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3